{"id":28593,"date":"2014-08-18T09:16:37","date_gmt":"2014-08-18T13:16:37","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=28593"},"modified":"2014-08-18T09:16:37","modified_gmt":"2014-08-18T13:16:37","slug":"pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593","title":{"rendered":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 <strong>Pfizer Inc. (NYSE:PFE)<\/strong>, a $182 billion market capped company whose shares are down 6.5% this year, does not hide its intentions to renounce its U.S. <a href=\"http:\/\/www.bidnessetc.com\/24205-pfizer-continuing-the-search-for-tax-inversion\/\" target=\"_blank\">corporate citizenship<\/a> to pursue tax havens in Europe.<\/p>\n<p style=\"text-align: justify;\">Shares of the company declined 0.31% to $28.64 on Friday, marking another day of decline.<\/p>\n<p style=\"text-align: justify;\">Talking about seeking tax haven, Pfizer tried to bid for the U.K.-based <strong>AstraZeneca plc (ADR) (NYSE:AZN) <\/strong>in which it offered about $117 billion, but the bid flopped as AstraZeneca declined to accept the offer. Given the U.K. takeover laws, Pfizer can only make another advance for AstraZeneca after six months. Many analysts have maintained that Pfizer Inc. (NYSE:PFE) could make another bid for AstraZeneca when another opportunity comes.<\/p>\n<p style=\"text-align: justify;\"><strong>Acquisition approach<\/strong><\/p>\n<p style=\"text-align: justify;\">However, the company is also looking for other deal that can support its agenda. No specific names have been mentioned about companies that Pfizer is circling for a deal that would boosting its tax inversion plans, but it is looking at a good potential partner in Europe. A move to Europe is expected to save the company millions or even billions of dollars in tax savings.<\/p>\n<p style=\"text-align: justify;\"><strong>Legal approach<\/strong><\/p>\n<p style=\"text-align: justify;\">Besides seeking buyout opportunities in Europe, Pfizer Inc. (NYSE:PFE) is also seeking for political solutions to its tax challenges. The reason many U.S. companies, especially drug firms, are seeking to move their tax headquarters to Europe is that the region offers favorable tax environment compared with the U.S. As such, Pfizer is seeking to have lawmakers address the tax issue so that U.S. companies can be comfortable being at home.<\/p>\n<p style=\"text-align: justify;\">According to Pfizer\u2019s CEO, Ian Read, they are lobbying Congress to support tax reforms on disadvantageous tax policies, mostly those that hurt the healthcare companies. However, the challenge with political approach to the tax issue is that it might take several years, which is why Pfizer Inc. (NYSE:PFE) is keen for an acquisition deal.<\/p>\n<p style=\"text-align: justify;\">To meet the tax inversion threshold, analysts say that Pfizer\u2019s acquisition would be in the tune of $100 billion, especially given its more than $180 billion market value.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Pfizer Inc. (NYSE:PFE), a $182 billion market capped company whose shares are down 6.5% this year, does not hide its [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":22248,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4503,8026,4504,993,2745],"stock_ticker":[],"class_list":["post-28593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astrazeneca-plc-adr-nyseazn","tag-ian-read","tag-nyseazn","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Pfizer Inc. (NYSE:PFE), a $182 billion market capped company whose shares are down 6.5% this year, does not hide its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-18T13:16:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"284\" \/>\n\t<meta property=\"og:image:height\" content=\"177\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good\",\"datePublished\":\"2014-08-18T13:16:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\"},\"wordCount\":363,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"keywords\":[\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"Ian Read\",\"NYSE:AZN\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\",\"name\":\"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"datePublished\":\"2014-08-18T13:16:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"width\":284,\"height\":177},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR","og_description":"Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Pfizer Inc. (NYSE:PFE), a $182 billion market capped company whose shares are down 6.5% this year, does not hide its [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-18T13:16:37+00:00","og_image":[{"width":284,"height":177,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good","datePublished":"2014-08-18T13:16:37+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593"},"wordCount":363,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","keywords":["Astrazeneca Plc (ADR) (NYSE:AZN)","Ian Read","NYSE:AZN","NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593","name":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","datePublished":"2014-08-18T13:16:37+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","width":284,"height":177},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfes-multipronged-approach-to-tax-issue-whichever-comes-first-is-good-28593#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc. (NYSE:PFE)\u2019s Multipronged Approach To Tax Issue, Whichever Comes First Is Good"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=28593"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28593\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/22248"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=28593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=28593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=28593"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=28593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}